JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kulick, M. B.
Right arrow Articles by von Kügelgen, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kulick, M. B.
Right arrow Articles by von Kügelgen, I.

Vol. 303, Issue 2, 520-526, November 2002

P2Y-Receptors Mediating an Inhibition of the Evoked Entry of Calcium through N-Type Calcium Channels at Neuronal Processes

Melanie B. Kulick and Ivar von Kügelgen

Department of Pharmacology, University of Bonn, Bonn, Germany

In the search for P2-receptors modulating the stimulation-evoked entry of calcium at processes of PC12 cells differentiated in the presence of nerve growth factor and neurotrophin-3, electrically evoked increases in free calcium were assessed by fura-2 microfluorimetry. Omission of calcium and addition of cadmium (100 µM) or the N-type calcium channel blocker omega -conotoxin GVIA (0.5 µM) abolished or markedly reduced the evoked responses. The P2Y-receptor agonists 2-methylthio adenosine 5'-diphosphate (2-methylthio-ADP), ADP, and adenosine 5'-O-(2-thiodiphosphate) (ADPbeta S) inhibited the electrically evoked entry of calcium without any changes in basal calcium concentrations. 2-Methylthio-ADP was the most potent agonist. Adenosine, P1,P4-di(adenosine-5')-tetraphosphate (Ap4A), UDP, and UTP (30 µM each) had no effect. The effect of ADPbeta S (30 µM) was abolished by the P2-antagonists reactive blue 2 (3 µM), suramin (100 µM), 2-methylthio-AMP (10 µM), p-chloromercuriphenyl sulfonic acid (1 µM), and AR-C 69931MX [N6-(2-methylthioethyl)-2-(3,3,3-trifluoropropylthio)-beta ,gamma -dichloromethylene adenosine 5'-triphosphate] (300 nM). In contrast, pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid (10 µM), the selective P2Y1-receptor antagonist MRS 2179 (N6-methyl-2'-deoxyadenosine 3',5'-bisphosphate; 10 µM), as well as the adenosine A1-receptor antagonist DPCPX (8-cyclopentyl-1,3-dipropylxanthine; 100 nM), caused no change. Pretreatment with pertussis toxin abolished the effect of ADPbeta S. Reverse transcriptase-polymerase chain reaction revealed the presence of mRNA for P2Y12-receptors in nondifferentiated and differentiated PC12 cells. The results indicate that processes of differentiated PC12 cells possess P2Y12-receptors coupling to pertussis toxin-sensitive G-proteins and mediating an inhibition of the stimulation-evoked entry of calcium through omega -conotoxin GVIA-sensitive calcium channels. This suggests a role of P2Y12-receptors in neuromodulation in addition to their involvement in platelet aggregation.


0022-3565/02/3032-0520$07.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
K. Hoffmann, Y. Baqi, M. S. Morena, M. Glanzel, C. E. Muller, and I. von Kugelgen
Interaction of New, Very Potent Non-Nucleotide Antagonists with Arg256 of the Human Platelet P2Y12 Receptor
J. Pharmacol. Exp. Ther., November 1, 2009; 331(2): 648 - 655.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
C. N. Morrell, H. Sun, M. Ikeda, J.-C. Beique, A. M. Swaim, E. Mason, T. V. Martin, L. E. Thompson, O. Gozen, D. Ampagoomian, et al.
Glutamate mediates platelet activation through the AMPA receptor
J. Exp. Med., March 17, 2008; 205(3): 575 - 584.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. J. Ennion, A. D. Powell, and E. P. Seward
Identification of the P2Y12 Receptor in Nucleotide Inhibition of Exocytosis from Bovine Chromaffin Cells
Mol. Pharmacol., September 1, 2004; 66(3): 601 - 611.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Z. Gerevich, S. J. Borvendeg, W. Schroder, H. Franke, K. Wirkner, W. Norenberg, S. Furst, C. Gillen, and P. Illes
Inhibition of N-Type Voltage-Activated Calcium Channels in Rat Dorsal Root Ganglion Neurons by P2Y Receptors Is a Possible Mechanism of ADP-Induced Analgesia
J. Neurosci., January 28, 2004; 24(4): 797 - 807.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. Queiroz, C. Talaia, and J. Goncalves
ATP Modulates Noradrenaline Release by Activation of Inhibitory P2Y Receptors and Facilitatory P2X Receptors in the Rat Vas Deferens
J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 809 - 815.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics.